NCT05458752View on ClinicalTrials.gov

Pneumocystis Jirovecii Pneumonia in Non-HIV-infected Immunocompromised Patients

CompletedOBSERVATIONAL
Enrollment

133

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

June 1, 2023

Study Completion Date

July 1, 2023

Conditions
Pneumocystis Jirovecii Infection
Trial Locations (1)

54511

Université de Lorraine, CHRU Nancy and APEMAC, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT05458752 - Pneumocystis Jirovecii Pneumonia in Non-HIV-infected Immunocompromised Patients | Biotech Hunter | Biotech Hunter